Repetitive Transcranial Magnetic Stimulation for Alcohol Use Disorder
Therapeutic Effects of Repetitive Transcranial Magnetic Stimulation on Alcohol Use Disorder: A One-Year, Randomized, Double-Blind MRI Tracking Study
2 other identifiers
interventional
9
1 country
1
Brief Summary
This study looked at whether repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation treatment, could help adults with alcohol use disorder when added to their usual treatment. Nine adults receiving abstinence-oriented care received 10 sessions of stimulation over the right front part of the brain. Drinking severity, mood, craving and quality of life were assessed before treatment, immediately after the 10 sessions, and again at one and three months. Brain scans were also obtained at these visits to examine whether stimulation was associated with changes in brain connections. The study had no comparison group, so the results cannot show whether any change was caused by the stimulation.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 14, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
June 14, 2026
CompletedFirst Submitted
Initial submission to the registry
August 5, 2026
CompletedFirst Posted
Study publicly available on registry
August 10, 2026
CompletedAugust 10, 2026
August 1, 2026
1 year
August 5, 2026
August 5, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Alcohol Use Disorders Identification Test (AUDIT) total score
AUDIT total score, range 0 to 40, with higher scores indicating more severe alcohol-related problems. Change from baseline was assessed at each follow-up.
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
Secondary Outcomes (7)
Change in Patient Health Questionnaire-9 (PHQ-9) score
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
Change in craving visual analogue scale score
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
Change in WHOQOL-BREF total score
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
Change in resting-state functional connectivity
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
Change in white matter diffusion metrics
Baseline, after the tenth stimulation session (median 2 days), 1 month, and 3 months
- +2 more secondary outcomes
Study Arms (1)
Active rTMS
EXPERIMENTALTen sessions of active repetitive transcranial magnetic stimulation over the right dorsolateral prefrontal cortex (F4), at 10 Hz and 110% of the visually determined resting motor threshold, 60 trains of five seconds each, 3,000 pulses per session over approximately 30 minutes, delivered on consecutive weekdays. All participants received active stimulation in addition to usual abstinence-oriented care, which included pharmacological and psychosocial treatment that was not protocolized.
Interventions
High-frequency repetitive transcranial magnetic stimulation
Eligibility Criteria
You may qualify if:
- Adults aged 20 to 65 years
- Diagnosis of alcohol use disorder according to DSM-5 criteria
- Able to provide written informed consent and complete study procedures
You may not qualify if:
- Moderate to severe alcohol withdrawal
- Psychiatric symptoms interfering with alcohol use disorder treatment
- Acute physical illness requiring hospitalization
- Standard contraindications to repetitive transcranial magnetic stimulation
- Pregnancy or planned pregnancy within one year
- Formal disability certification related to a psychiatric disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ting-Gang Changlead
Study Sites (1)
Taichung Veterans General Hospital, Taiwan
Taichung, Taiwan, 407219, Taiwan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief, Division of Addiction Medicine, Department of Psychiatry, Taichung Veterans General Hospital, Taiwan
Study Record Dates
First Submitted
August 5, 2026
First Posted
August 10, 2026
Study Start
June 10, 2025
Primary Completion
June 14, 2026
Study Completion
June 14, 2026
Last Updated
August 10, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual-level data are not publicly available given the small sample and the potentially identifiable nature of the clinical data; de-identified data and analysis code may be made available by the corresponding author on reasonable request, subject to institutional review board approval.